A show from IDEA Pharma. Hosted by Chief Medical Officer, Dr Alexander Gray, this show will focus on deep dives into subjects of interest for the development of more great medicines
Deep Medicine
Claim This Podcastby IDEA Pharma
4 episodes
Updated Daily
Accepts GuestsHas SponsorsLocation 🇬🇧
Podcast Overview
A show from IDEA Pharma. Hosted by Chief Medical Officer, Dr Alexander Gray, this show will focus on deep dives into subjects of interest for the development of more great medicines
Language
🇺🇲
Publishing Since
12/30/2022
1 verified contact email on file for Deep Medicine
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
June 8, 2023
Deep Medicine | Childhood trauma and the development of adult affective disorders: correlation or causation?
Childhood trauma and the development of adult affective disorders: correlation or causation?
May 5, 2023
Alzheimer’s of the heart
Unraveling the role of amyloid in cardiomyopathy
February 9, 2023
Deep Medicine | Avoiding the needle: how new imaging techniques are transforming prostate cancer detection
Welcome to this, the second in the series of Deep Medicine, with your Host Alexander Gray: the Chief Medical Officer of IDEA Pharma. Today Alex has been joined by Mark Emberton, Dean, Faculty of Medical Sciences, University College London, Professor of Interventional Oncology, Division of Surgery and Interventional Science, UCL, and an Honorary Consultant Urologist at University College London Hospitals NHS Trust. Mark has been at the forefront of imaging techniques for early prostate cancer detection, changing the detection paradigm in UK (and beyond) through his pioneering work with MRI. He has also driven the practice of minimally-invasive treatment techniques such as HIFU for early prostate cancer treatment. Alex had a chance to discuss state-of-the-art in early detection with Mark, and consider where future data might lead us in better detecting, categorizing, and managing early prostate cancer.
4 total episodes available
Deep-dive analytics for Deep Medicine
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Deep Medicine?
- How often does this podcast release new episodes?
This podcast updates daily.
- Where can I listen to this podcast?
This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.